期刊文献+

帕利哌酮缓释片与奥氮平治疗精神分裂症患者的对照研究 被引量:7

下载PDF
导出
摘要 为进一步探讨帕利哌酮缓释片治疗精神分裂症的疗效及安全性,现以奥氮平为对照进行临床研究,报告如下。
作者 杨栋 谌益华
出处 《临床精神医学杂志》 2012年第4期263-263,共1页 Journal of Clinical Psychiatry
  • 相关文献

参考文献2

二级参考文献7

  • 1Dremeneov E, Mansani MEI, Blier P, et al. Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons[ J ]. Psychopharmacology ,2007, 194:63-72.
  • 2Aravagin M, Marder SR. Brain, plasma and tissue phannacokinetics of risperidone and hydroxyrisperidone after separate oral administration to rats [ J ], Psychopharmacology,2002,159:424-431.
  • 3Manickam A, Arthur Y,Stephen R. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxylisperidone in the brain and other tissues of rat[ J]. Psyehopharmacology, 1998,139 : 356-363.
  • 4Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds [ J]. Life Sei ,2000,68:29-39.
  • 5Davidson M, Emsley R, Kramer M, et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER) : Results of a 6-week, randomized, placebo-controlled study [ J ]. J Schizophrenia Research ,2007,93 : 117-130.
  • 6Fowler JA, Bettinger TL, Argo TR. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia[J].Clin Ther,2008 ,30 :231-248.
  • 7Kramer M, Kushner S, Vijapurkar U, et al. Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia : a randomized, double-blind, plaeebo-eontroned study[J].Clin Psychopharmacol, 2007,27 : 6 - 14.

共引文献15

同被引文献76

  • 1张鸿燕,李华芳,王刚,等.帕利哌酮缓释片治疗急性精神分裂症疗效及安全性的对照研究[J].中华精神科杂志,2011,24(6):441-443.
  • 2Lieberman J.A, Stroup T.S, MeEvoy J.P,et al.Effectiveness of antipsy- chotic drugs in patients with chronic schizophrenia. N.Engl [J].J.Med, 2005,353(12):1209-1223.
  • 3Jones P.B,Barnes T.R, Davies L,Dunn G,et al. Randomized controlled trial of the effect on quality of life of second vs first-generation antipsy- chotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUTLASS1). Areh.Gen J.Psychiatry, 2006,63(10):1079-1087.
  • 4沈渔邨.精神病学[M].5版.北京人民卫生出版社,2009:844-845.
  • 5Boutros NN, Kirollos SB, Pogarell O, et al. Predictive value of isolated epileptiform discharges for a favorable therapeutic response to antiepi- leptic drugs in nonepileptic psychiatric patients [ J ]. J Clin Neurophys- iol,2014,31 ( 1 ) :21-30.
  • 6Boutros NN, Ghosh S, Khan A, et al. Anticonvulsant medications for panic disorder:a review and synthesis of the evidence[ J]. Int J Psy- chiatry Clin Pract ,2014,18 ( 1 ) :2-10.
  • 7Jonsson G, Davies N, Freeman C, et al. Management of mental health disorders in HIV-positive patients[ J]. South Afr J HIV Med,2013,14 (4) 155-165.
  • 8Sakarya D, Gunes C, Ozturk E, et al. ' Vampirism' in a Case of Disso- ciative Identity Disorder and Post-Traumatic Stress Disorder[ J ]. Psy- ehother Psychosom, 2012,81 ( 5 ) : 322 -323.
  • 9Every-Palmer S, Norris J. Not guilty by reason of epilepsy. Post-ictal delirium and psychosis resulting in violent offending[ J]. Aust N Z J Psychiatry,2013,47(10) :961-962.
  • 10Wu C,Li A,Leng Y, et al. ttistone deaeetylase inhibition by sodium valproate regulates polarization of macrophage subsets [ J ]. DNA Cell Biol,2012,31 (4) :592-599.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部